Trademark: 79302155
Word
RAZILKA
Status
Dead
Status Code
404
Status Date
Friday, December 10, 2021
Serial Number
79302155
Registration Number
6458412
Registration Date
Tuesday, August 24, 2021
Mark Type
4000
Filing Date
Wednesday, November 18, 2020
Published for Opposition
Tuesday, June 8, 2021
Cancellation Date
Monday, September 6, 2021

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Events
Oct 15, 2021
Final Disposition Reviewed - No Action Required By Office
Sep 24, 2021
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Sep 24, 2021
Death Of International Registration
Sep 23, 2021
Grant Of Protection Created, To Be Sent To Ib
Aug 24, 2021
Registered-Principal Register
Jun 8, 2021
Published For Opposition
May 19, 2021
Notice Of Publication
May 5, 2021
Approved For Pub - Principal Register
Apr 30, 2021
Assigned To Examiner
Jan 26, 2021
Application Filing Receipt Mailed
Jan 21, 2021
New Application Office Supplied Data Entered In Tram
Jan 19, 2021
Limitation From Original Application Entered
Jan 14, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24